SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children.

Authors:
Folga BA; Karpenko CJ; Grygiel-Górniak B.

Journal:
Med Microbiol Immunol

Publication Year: 2022

DOI:
10.1007/s00430-022-00756-3

PMCID:
PMC9672612

PMID:
36396785

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med Microbiol Immunol

Abbreviation: Med Microbiol Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Inflammation, the kynurenines, and mucosal injury during human experimental enterotoxigenic Escheri…
Rim S; Vedøy OB; Brønstad I and 4 more (2024) - Transparency Score: 5/6
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.
Haycroft ER; Davis SK; Ramanathan P and 15 more (2023) - Transparency Score: 3/6
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of c…
Osterman A; Krenn F; Iglhaut M and 19 more (2023) - Transparency Score: 3/6
Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical s…
Kierzkowska M; Majewska A; Karłowicz K and 1 more (2023) - Transparency Score: 3/6
Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -B…
Krenn F; Dächert C; Badell I and 17 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare no competing interests. Ethical approvalNot applicable. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding The authors declare that they have no financial support."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025